Sort
16,300 grants matching “fatty liver disease”
Cholesterol Ester Hydrolysis and cholesterol efflux
$17,913Shobha Ghosh · Virginia Commonwealth University · R01 · FY2008 · HL
MECHANISM OF EXCESS GLUCOSE PRODUCTION IN TYPE 2 DIABETES
$17,838Eunsook Jin · Ut Southwestern Medical Center · P41 · FY2009 · RR
NON-ALCOHOLIC FATTY LIVER DISEASE
$17,838Jeff L Browning · Ut Southwestern Medical Center · P41 · FY2009 · RR
HEPATIC FLUXES IN PGC-1 ALPHA KO MICE
$17,838Brian N Finck · Ut Southwestern Medical Center · P41 · FY2009 · RR
OFFSPRING POSTNATAL CARDIOVASCULAR HEALTH
$17,823Laura A Cox · Texas Biomedical Research Institute · P51 · FY2011 · RR
CLINICAL TRIAL: TREATMENT OF NONALCOHOLIC STEATOHEPATITIS IN CHILDREN (TONIC
$17,775Stephanie H Abrams · Baylor College Of Medicine · M01 · FY2009 · RR
Complement and ethanol-induced liver injury.
$17,768Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · AA
Effect Of Diet and Other Early Exposures on Child Health and Development
$17,691Matthew P Longnecker · Environmental Health Sciences · Z01 · FY2007 · ES
NON-ALCOHOLIC FATTY LIVER DISEASE AND OBESITY
$17,663Washington University · M01 · FY2005 · RR
Role of Protein Malonylation in Regulating Mitochondrial Function
$17,603Kelsey Fisher-Wellman · Duke University · F32 · FY2017 · DK
HUMAN P450 ENZYMES AND THEIR TOXICOLOGICAL IMPACT
$17,454La Jolla Inst For Molecular Medicine · R01 · FY2002 · AA
Omega-3 Fatty Acid Suppression of Silica-induced Inflammasome Activation in a Novel Alveolar Macrophage Model
$17,423Kathryn Alexandria Wierenga · Michigan State University · F31 · FY2021 · ES
EFFECT OF VISCERAL FAT ON INSULIN SENSITIVITY
$17,372Samuel Klein · Texas Biomedical Research Institute · P51 · FY2011 · RR
The effects of allelic variation in Pparg on skeletal metabolism
$17,286Cheryl Lynne Ackert-Bicknell · Jackson Laboratory · F31 · FY2007 · AG
Characterizing the role of peroxiredoxin 6 in Alcoholic Liver Disease.
$17,255James R Roede · University Of Colorado Denver · F31 · FY2009 · AA
Elucidating the function of TM6SF2
$17,186Sarah Ashley Martin · Ut Southwestern Medical Center · F32 · FY2018 · DK
CLINICAL TRIAL: TREATMENT OF NONALCOHOLIC STEATOHEPATITIS IN CHILDREN (TONIC
$17,168Stephanie H Abrams · Baylor College Of Medicine · M01 · FY2010 · RR
Role of Complement Factor 5 in Adipose Tissue Inflammation and Insulin Resistance
$17,160Dario Alejandro Gutierrez · Vanderbilt University · F31 · FY2011 · DK
Regulation of Skeletal Muscle Angiogenesis by PGC-1 alpha
$17,069Srilatha Raghuram · Beth Israel Deaconess Medical Center · F32 · FY2012 · HL
Hepatobiliary Pathophysiology of Liver Regeneration
$16,933David A Rudnick · Washington University · R01 · FY2009 · DK
MASH Pathogenesis and Therapeutic Approaches
$16,900Terry L. Sheppard · Keystone Symposia · R13 · FY2025 · DK
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
$16,871John Anthony Haley · Univ Of Massachusetts Med Sch Worcester · F31 · FY2024 · DK
THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE
$16,855Arun J Sanyal · Virginia Commonwealth University · M01 · FY2007 · RR
The role of Trem2-expressing macrophages in atherosclerosis
$16,806Patrick Robert Lundgren · University Of Pennsylvania · F31 · FY2022 · HL
Treatment of breast cancer tumor growth and metastasis with an anti-MMP-9 DNAzyme
$16,800Miranda Alvina Marie Hallett · University Of Tennessee Health Sci Ctr · F31 · FY2011 · CA